Ignite Creation Date:
2026-03-26 @ 3:15 PM
Ignite Modification Date:
2026-03-30 @ 10:19 PM
Study NCT ID:
NCT07333066
Status:
NOT_YET_RECRUITING
Last Update Posted:
2026-01-12
First Post:
2025-12-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase III Randomized International Open Label Clinical Trial of Treatment Intensification With Docetaxel Plus Apalutamide in Patients With Metastatic Hormone-sensitive Prostate Cancer Who Did Not Achieve a Deep PSA Response After Initial Treatment With Apalutamide: REINFORCE Trial.
Sponsor:
Alianza multidisciplinar para la investigación de los tumores genitourinarios -GUARD
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2026-03-31
Start Date Type:
ESTIMATED
Primary Completion Date:
2030-03-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-03-31
Completion Date Type:
ESTIMATED
First Submit Date:
2025-12-30
First Submit QC Date:
None
Study First Post Date:
2026-01-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-30
Last Update Post Date:
2026-01-12
Last Update Post Date Type:
ACTUAL